Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "President CEO Epicentre Biotechnologies"

17:43 EDT 24th July 2014 | BioPortfolio

Matching Channels

Drug Development for Rare Diseases

The economics of any industry relies on a large demand for a particular product; this applies to the pharmaceutical industry where efforts are focused on big and relatively straight-forward diseases...

Matching News

immatics biotechnologies GmbH - Product Pipeline Review - 2014

immatics biotechnologies GmbH - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘immatics biotechnologies GmbH - Product Pipeline Review - 2014’, provides an overview of the imma...

Adaptive Biotechnologies secures $105M from private investor

Adaptive Biotechnologies said it has raised $105 million in private funding from Viking Global Investors, bringing its total  -More- 

Avalanche Biotechnologies seeks to go public

Ophthalmic drug developer Avalanche Biotechnologies Inc. filed for its initial public offering.

Adaptive Biotechnologies raises $5mm through Series C; later adds $5mm more

Adaptive Biotechnologies Corp. (formerly Adaptive TCR; immune system profiling for diagnostics and drug development) raised $5mm from three investors in its Series C round.

Fujifilm Diosynth Biotechnologies Continues Expansion of R&D Facilities

Fujifilm Diosynth Biotechnologies has announced continued expansion of its process development capabilities with the investment of over US$5.6m in new laboratories and equipment at both its Billingham...

Département Environnement et Agro-biotechnologies use Nanoparticle Tracking Analysis

Researchers from the Département Environnement et Agro-biotechnologies at the CRP - Gabriel Lippmann in Luxembourg use Nanoparticle Tracking Analysis for toxicology studies  The Dép...

Stellar Biotechnologies Launches New Corporate Website / The New Website Showcases Stellar's Core KLH Products, Breakthroughs in Aquaculture Science, and Strategic Expansion of its Immunotherapy Program in a User-friendly Platform

PORT HUENEME, CA -- (Marketwired) -- 05/02/14 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the launch of its new corporate websit...

Roth starts Lion Biotechnologies at buy

Roth Capital Partners has initiated coverage of Lion Biotechnologies (OTC:LBIO) with a “buy” rating and $10 price target. The stock closed at $6 on Wednesday. Lion, formerly Genesis Biopharma, is...

Matching PubMed Articles

Changing times, similar challenges.

With IHEEM celebrating its 70th Anniversary this month, HEJ editor, Jonathan Baillie, recently met the Institute's oldest surviving Past-President, Lawrence Turner OBE, who, having in 1964 established...

Biotechnologies in developing countries: present and future.

A Message from your President.

Address of the new president.

Challenges for new ERC president.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement